HLA analysis in ACTH deficiency due to immune-related adverse events of PD1 antibody

HLA analysis in ACTH deficiency due to immune-related adverse events of PD1 antibody - HLA analysis in ACTH deficiency due to irAE of PD1 antibody

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040239

Enrollment

Registered

2020-05-11

Start date

2020-06-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACTH deficiency

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ACTH deficiency patients due to PD1 antibody therapy for malignant tumor in Kochi Medical School hospital.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Analysis of specific HLA genotypes in PD1-Ab induced ACTH deficiency patients	—

Countries

Japan

Contacts

Public ContactMITSURU NISHIYAMA

Kochi Medical School, Kochi University Department of Endocrinology, Metabolism & Nephrology

nisiyamm@kochi-u.ac.jp088-880-2343

Outcome results